MAC DADDY PURPLE Capsules — Class I drug recall D-0563-2022
Terminated recall by ABC Sales 1 Inc, reported 2022-02-23, distributed nationwide. Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil and/or sildenafil, in
| Recall number | D-0563-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ABC Sales 1 Inc, Monsey, NY, United States |
| Recall initiated | 2022-02-08 |
| Classified | 2022-02-17 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2022-03-04 |
| Distributed | Nationwide (US) |
| Quantity | 336 cartons |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 1230005 |
| Expiration dates | 2024-03-30 |
Product
MAC DADDY PURPLE Capsules, packaged in 10-count blisters per carton, ASIN B08Z63Z4QK, UPC 742137 605764.
Reason for recall
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil and/or sildenafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making these unapproved drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0563-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.